DS-1971a

potent, selective NaV1.7 ion channel inhibitor

completed Ph. I in HV, discontinued in Ph. II

from optimization of known starting point

J. Med. Chem., May 26, 2020

Daiichi Sankyo, Tokyo, JP

DS-1971a is a potent, isoform-selective selective arylsulfonamide NaV1.7 inhibitor intended for the treatment of neuropathic pain. It has a surprisingly long residence time on NaV1.7, which the authors suggest contributes…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks